Hua Medicine's Second-Generation GKA HM-002-1005 Completes Phase Ia Study in the US
CompanyDrug

Hua Medicine’s Second-Generation GKA HM-002-1005 Completes Phase Ia Study in the US

Shanghai MicuRx's MRX-4/Contezolid Meets Primary Endpoint in Phase III cSSTI Study
CompanyDrug

Shanghai MicuRx’s MRX-4/Contezolid Meets Primary Endpoint in Phase III cSSTI Study

CBC Group and Mubadala Acquire UCB's Neurology and Allergy Business in China for $680 Million
CompanyDeals

CBC Group and Mubadala Acquire UCB’s Neurology and Allergy Business in China for $680 Million

Simcere Zaiming Launches Phase III Trial for SERD Inhibitor SIM0270 in Breast Cancer
CompanyDrug

Simcere Zaiming Launches Phase III Trial for SERD Inhibitor SIM0270 in Breast Cancer

Hua Medicine's SENSITIZE Study Illuminates Dorzagliatin's β-Cell Glucose Sensitivity Mechanism
CompanyDrug

Hua Medicine’s SENSITIZE Study Illuminates Dorzagliatin’s β-Cell Glucose Sensitivity Mechanism

Sunflower Pharmaceutical Group to Establish Joint Lab with Peking University for Bacterial Enzyme Research
CompanyDeals

Sunflower Pharmaceutical Group to Establish Joint Lab with Peking University for Bacterial Enzyme Research

Simcere Pharmaceutical's Edaravone and Borneol Sublingual Tablets Approved for AIS Treatment in China
CompanyDrug

Simcere Pharmaceutical’s Edaravone and Borneol Sublingual Tablets Approved for AIS Treatment in China

Shanghai Pharmaceuticals Concludes Phase II Study for I037 in Acute Ischemic Stroke
CompanyDrug

Shanghai Pharmaceuticals Concludes Phase II Study for I037 in Acute Ischemic Stroke

Affinity (Shanghai) Secures Over RMB 400 Million in Series B2 Financing to Advance Oncology Drugs
CompanyDeals

Affinity (Shanghai) Secures Over RMB 400 Million in Series B2 Financing to Advance Oncology Drugs

Abogen Biosciences and Ruijin Hospital Launch Ruijin Abogen Nucleic Acid Drug Research Institute
CompanyDeals

Abogen Biosciences and Ruijin Hospital Launch Ruijin Abogen Nucleic Acid Drug Research Institute

Henlius Biotech Initiates US Commercial Supply of Hanquyou, Biosimilar to Herceptin
CompanyDrug

Henlius Biotech Initiates US Commercial Supply of Hanquyou, Biosimilar to Herceptin

ImmuneOnco Biopharmaceuticals Receives NMPA Approval for Lupus Nephritis Phase II Study
CompanyDrug

ImmuneOnco Biopharmaceuticals Receives NMPA Approval for Lupus Nephritis Phase II Study